James Merryweather, Geert Nygaard, Stan Fronczkowski, Faye Coggins | GenomeWeb
Ciphergen Biosystems last week said that James Merryweather will resign as executive vice president of sales and marketing.
 
Merryweather “principally supported” Ciphergen’s tools business, which the company sold to Bio-Rad late last year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.